Sputnik International
November 18, 2021
WASHINGTON (Sputnik) – The US government has agreed to purchase 10 million doses of an oral anti-viral medication that targets the virus responsible for COVID-19, provided the medication receives approval by the Food and Drug Administration, Pfizer said on Thursday.
“Under the terms of the agreement, the U.S. government will acquire 10 million treatment courses to be delivered by Pfizer beginning later this year and concluding in 2022. Pfizer will receive $5.29 billion from the U.S. government, pending and contingent upon regulatory authorization,” Pfizer said in a press release.